Skip to main navigation Skip to search Skip to main content

Rectal cancer, version 2.2018 clinical practice guidelines in Oncology

  • Al B. Benson
  • , Alan P. Venook
  • , Mahmoud M. Al-Hawary
  • , Lynette Cederquist
  • , Yi Jen Chen
  • , Kristen K. Ciombor
  • , Stacey Cohen
  • , Harry S. Cooper
  • , Dustin Deming
  • , Paul F. Engstrom
  • , Jean L. Grem
  • , Axel Grothey
  • , Howard S. Hochster
  • , Sarah Hoffe
  • , Steven Hunt
  • , Ahmed Kamel
  • , Natalie Kirilcuk
  • , Smitha Krishnamurthi
  • , Wells A. Messersmith
  • , Jeffrey Meyerhardt
  • Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Evan Wuthrick, Deborah A. Freedman-Cass, Kristina M. Gregory, Lisa Gurski
  • Northwestern University
  • University of California at San Francisco
  • University of Michigan, Ann Arbor
  • University of California at San Diego
  • City of Hope National Medical Center
  • Vanderbilt University
  • Seattle Cancer Care Alliance
  • University of Wisconsin-Madison
  • Fox Chase Cancer Center
  • University of Nebraska Medical Center
  • Mayo Clinic
  • Yale University
  • University of South Florida
  • Washington University St. Louis
  • University of Alabama at Birmingham
  • Stanford University
  • Case Western Reserve University
  • University of Colorado Cancer Center
  • Dana-Farber Cancer Institute
  • Roswell Park Comprehensive Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • University of Utah
  • University of Tennessee Health Science Center
  • University of Texas MD Anderson Cancer Center
  • Johns Hopkins University
  • Duke University
  • Ohio State University

Research output: Contribution to journalArticlepeer-review

528 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer. This portion of the guidelines focuses on the management of localized disease, which involves careful patient selection for curative-intent treatment options that sequence multimodality therapy usually comprised of chemotherapy, radiation, and surgical resection.

Original languageEnglish
Pages (from-to)874-901
Number of pages28
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antineoplastic Combined Chemotherapy Protocols/standards
  • Biopsy
  • Chemoradiotherapy/methods
  • Disease-Free Survival
  • Humans
  • Incidence
  • Induction Chemotherapy/methods
  • Medical Oncology/standards
  • Neoadjuvant Therapy/methods
  • Neoplasm Recurrence, Local/diagnosis
  • Neoplasm Staging
  • Patient Selection
  • Proctectomy/methods
  • Randomized Controlled Trials as Topic
  • Rectal Neoplasms/diagnosis
  • Rectum/pathology
  • Societies, Medical/standards
  • United States/epidemiology
  • Watchful Waiting/methods

Fingerprint

Dive into the research topics of 'Rectal cancer, version 2.2018 clinical practice guidelines in Oncology'. Together they form a unique fingerprint.

Cite this